COMMUNIQUÉS West-GlobeNewswire

Serenity Medical Receives U.S. FDA Breakthrough Device Designation for The Serenity Shepherd Stent™ System to Treat Pulsatile Tinnitus
30/06/2026
Second FDA Regulatory Milestone for Serenity’s Novel Platform, Following the Recent HDE Approval of the River Stent™ – First Venous Stent for Severe, Refractory Idiopathic Intracranial Hypertension (IIH) HARRISON, N.Y [...]
Nelipak Healthcare Packaging receives ISCC PLUS certification for Clara, Ireland production facility
30/06/2026
ISCC certification reflects Nelipak’s commitment to supporting customers with innovative and sustainable packaging solutions CRANSTON, R.I., June 30, 2026 (GLOBE NEWSWIRE) -- Nelipak Corporation (“Nelipak”), a leading [...]
AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services
30/06/2026
New collaboration delivers streamlined integration from drug substance to drug product, including sterile fill-finish and device assembly for clinical programs. SEATTLE, June 30, 2026 (GLOBE NEWSWIRE) -- Drug developers [...]
Celebrate the Fourth—Without Damaging Your Hearing or Losing Your Voice
30/06/2026
Fireworks, Festivals, and Summer Celebrations Can Be Tough on Your Ears and Voice. Simple Steps Can Help You Enjoy the Fun Safely. Rockville, MD, June 30, 2026 (GLOBE NEWSWIRE) -- Independence Day is one of the loudest [...]
Imprivata Research Finds that Only 32% of Public Safety Agencies are Fully Compliant with Criminal Justice Information Services Requirements
30/06/2026
Nearly all public safety professionals report access and security friction when accessing critical systems, highlighting challenges to achieving CJIS compliance WALTHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- [...]
Ally Medical ER Continues Its Austin-Area Growth With Cedar Park Opening
30/06/2026
Ally Medical ER Cedar Park is open, bringing 24/7 emergency care to one of the Austin area’s most beloved communities. CEDAR PARK, Texas, June 30, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency Room is now open at [...]
PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited
30/06/2026
DELRAY BEACH, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds” or the “Company”) (Nasdaq: PETS) today confirmed that its Board of Directors (the “Board”) has received an unsolicited, non-binding, [...]
Biosphere Expands Biomanufacturing Platform with NovoNutrients Acquisition
30/06/2026
Acquisition strengthens Biosphere’s advanced bioreactor platform and accelerates development of bioproducts across defense, industrial and commercial markets OAKLAND, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Biosphere [...]
Travel Fatigue Treatments Gain Traction as Summer Travel Increases, Says Prana IV Therapy
30/06/2026
SCOTTSDALE, Ariz., June 30, 2026 (GLOBE NEWSWIRE) -- In a review published in the National Library of Medicine , researchers found that jet lag can significantly impair sleep quality, alertness, cognitive performance, [...]
SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards
30/06/2026
Company celebrated for advancing global access to its innovative robotic surgery platform FORT LAUDERDALE, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS [...]
Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling
30/06/2026
- Milestone an important step in launching Trinovium within the global AI data center ecosystem - Data center liquid cooling market projected to expand from $4 billion in 2026 to $27 billion by 2033 1 DUBLIN and [...]
Cosmos Health Authorizes Up to $5 Million Share Repurchase Program
30/06/2026
CHICAGO, June 30, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that its Board of Directors [...]
LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations
30/06/2026
NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar [...]
InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos
30/06/2026
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient development plan to [...]
Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)
30/06/2026
Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria with a well-tolerated safety profile for [...]
FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients
30/06/2026
FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients AUSTIN, Texas, June 30, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) ( [...]
Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer
30/06/2026
- Proceeds will fund advancement of AR ON degrader, FX-111, to proof of concept and preclinical development of AR ON RIPTAC program - Veteran biotech executive, Anna Protopapas, appointed as CEO to guide company through [...]
Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors
30/06/2026
Brings more than 25 years of experience advancing and commercializing high-impact therapies for serious diseases, including those with limited or no approved treatment options Extensive public company and rare disease [...]
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
30/06/2026
Plus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026 Affirms 2026 guidance on key milestones Reports positive CNSide ® commercial progress HOUSTON, June 30, 2026 (GLOBE NEWSWIRE [...]

Pages